Mariner’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$449K Sell
20,367
-16,495
-45% -$287K ﹤0.01% 2570
2025
Q4
$435K Buy
36,862
+13,298
+56% +$171K ﹤0.01% 2548
2025
Q3
$373K Buy
+23,564
New +$342K ﹤0.01% 2636
2025
Q1
Sell
-12,834
Closed -$217K 3461
2024
Q4
$217K Sell
12,834
-826
-6% -$16.1K ﹤0.01% 2936
2024
Q3
$278K Sell
13,660
-10,113
-43% -$207K ﹤0.01% 2641
2024
Q2
$537K Sell
23,773
-3,348
-12% -$87.7K ﹤0.01% 1996
2024
Q1
$712K Sell
27,121
-31
-0.1% -$883 ﹤0.01% 1755
2023
Q4
$856K Sell
27,152
-952
-3% -$25.8K ﹤0.01% 1542
2023
Q3
$788K Buy
28,104
+503
+2% +$17.3K ﹤0.01% 1472
2023
Q2
$1.01M Buy
27,601
+193
+0.7% +$5.89K ﹤0.01% 1305
2023
Q1
$820K Sell
27,408
-7,865
-22% -$259K ﹤0.01% 1385
2022
Q4
$1.08M Sell
35,273
-3,034
-8% -$91K ﹤0.01% 1200
2022
Q3
$944K Buy
38,307
+5,542
+17% +$183K ﹤0.01% 1081
2022
Q2
$1.05M Buy
32,765
+3,194
+11% +$117K ﹤0.01% 890
2022
Q1
$931K Buy
29,571
+12,726
+76% +$398K ﹤0.01% 955
2021
Q4
$565K Buy
16,845
+161
+1% +$5.01K ﹤0.01% 976
2021
Q3
$485K Sell
16,684
-271
-2% -$8.77K ﹤0.01% 858
2021
Q2
$590K Buy
+16,955
New +$561K ﹤0.01% 764

Other funds holding CC

Mariner's CC Position: Q1 2026 in Review

Mariner reduced its Chemours (CC) stake by 45% in Q1 2026, selling an estimated $287K and leaving 20,367 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #2570.

Mariner first reported a position in CC in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.08M in Q4 2022. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Mariner held 20,367 shares of Chemours worth $449K as of Q1 2026.
  • Mariner sold 16,495 Chemours shares in Q1 2026, an estimated $287K.
  • Chemours made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2570 holding.
  • Mariner first reported a position in Chemours in Q2 2021 and has held it in 18 quarters since.
  • Mariner's Chemours position peaked at $1.08M in Q4 2022.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.